7 completed, 1 recruiting, 1 unknown. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 7, Recruiting 1, Unknown 1 |
Follow Type II Diabetes Mellitus: new trials by email Literature Review of Type II Diabetes Mellitus trials Research Report on Type II Diabetes Mellitus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study Empagliflozin - Type II Diabetes Mellitus, Efficacy, Self | Phase 4 | Recruiting | Getz Pharma | 2000 | 2021-04-01 | 2026-01-22 |
| Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus Empagliflozin, Usual care group - Type II Diabetes Mellitus | Phase 4 | Completed | Getz Pharma | 244 | 2019-06-01 | 2020-12-11 |
| Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy Pioglitazone, Metformin, Sulfonylurea - Type II Diabetes Mellitus | Phase 4 | Completed | Takeda | 114 | 2013-12-16 | 2018-09-12 |
| The Effect of Linagliptin on Mitochondrial and Endothelial Function Linagliptin, Placebo, Microcirculation testing - Type II Diabetes Mellitus | Phase 4 | Completed | Beth Israel Deaconess Medical Center | 45 | 2013-10-01 | 2016-11-18 |
| Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus Subetta, Placebo - Type II Diabetes Mellitus | Phase 4 | Completed | Materia Medica Holding | 190 | 2013-05-07 | 2019-05-31 |
| Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure vildagliptin, placebo of vildagliptin - Congestive Heart Failure, Type II Diabetes Mellitus | Phase 4 | Completed | Novartis Pharmaceuticals | 798 | 2009-05-01 | 2020-12-17 |
| Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes Mellitus gastric bypass, sleeve gastrectomy - Type II Diabetes Mellitus | Phase 4 | Unknown | Min-Sheng General Hospital | 120 | 2007-08-01 | 2008-11-14 |
| Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus Rosiglitazone - Type II Diabetes Mellitus | Phase 4 | Completed | Aristotle University Of Thessaloniki | 100 | 2005-01-01 | 2007-04-04 |
| Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease Trimetazidine - Coronary Artery Disease, Type II Diabetes Mellitus | Phase 4 | Completed | IRCCS San Raffaele | 30 | 1999-02-01 | 2006-01-26 |
Diabetes Mellitus, Type 2 (9) · Diabetes Mellitus (2) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Heart Failure (1) · Metabolic Diseases (1)
Endocrine System Diseases (9) · Glucose Metabolism Disorders (9) · Nutritional and Metabolic Diseases (9) · Metabolic Diseases (8) · Diabetes Mellitus (7) · Heart Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Myocardial Ischemia (1) · Vascular Diseases (1)
empagliflozin (2) · Gastric Bypass (1) · Linagliptin (1) · Magnetic Resonance Spectroscopy (1) · Metformin (1) · Pioglitazone (1) · Rosiglitazone (1) · Sulfonylurea Compounds (1) · Trimetazidine (1) · Vildagliptin (1) · subetta (1)
Getz Pharma (2) · Aristotle University Of Thessaloniki (1) · Beth Israel Deaconess Medical Center (1) · IRCCS San Raffaele (1) · Materia Medica Holding (1) · Min-Sheng General Hospital (1) · Novartis Pharmaceuticals (1) · Takeda (1)
Greece (2) · Pakistan (2) · Russia (2) · Afghanistan (1) · Czechia (1) · Denmark (1) · Estonia (1) · Germany (1) · Guatemala (1) · India (1) · Italy (1) · Kenya (1) · Latvia (1) · Lithuania (1) · Nigeria (1)
A H Aamir (1) · Christos Liapis, PhD,MD (1) · Giuseppe Marazzi, MD (1) · Lee WeiJei, M.D, Ph.D (1) · Umar Wahab (1)
PMID 17586747, PMID 18413173, PMID 20149706, PMID 21339423, PMID 22284243, PMID 27583476, PMID 29032139, PMID 34389003, PMID 36443769
2008 (1)